Incyte· @Incyte · X·· 2026-04-28精选AI 评分62
AI 导读
Incyte 在 2026 年第一季度财报电话会上宣布，其 STOP-V 临床试验项目在非节段型白癜风成人患者中取得 3 期阳性结果。公司同时提供了新闻稿链接以了解更多信息。
推荐理由
Incyte 在财报电话会上公布 STOP-V 项目 3 期阳性结果，读者可了解其在非节段型白癜风这一适应症上的研发进展。
正文
As shared this morning during our Q1 2026 earnings call, we announced positive Phase 3 results from our STOP-V clinical trial program in adult patients with nonsegmental vitiligo. Read our press release to learn more. https://bit.ly/4mT5HPc
来源：Incyte · x.com